Uniform Health-Care Decisions Act. National Conference of Commissioners on Uniform State Laws. Issues L & Med 2006;83(22):83-97.
Fine RL. The Texas advance directives act of 1999: politics and reality. HEC Forum. 2001;13(1):59-81.
Fine RL. Point: the Texas advance directives act effectively and ethically resolves disputes about medical futility. Chest. 2009;136(4):963-967.
Lightfoot L. The ethical health lawyer. Incompetent decisionmakers and withdrawal of life-sustaining treatment: a case study. J Law Med Ethics. 2005;33(4):851-856.
Veatch RM, Spicer CM. Medically futile care: the role of the physician in setting limits. Am J Law Med. 1992;18(1-2):15-36.
Kopelman LM. Conceptual and moral disputes about futile and useful treatments. J Med Philos. 1995;20(2):109-121.
Burns JP, Truog RD. Futility: a concept in evolution. Chest. 2007;132(6):1987-1993.
Chidwick P, Sibbald R. Physician perspectives on legal processes for resolving end-of-life disputes. Healthc Q. 2011;14(2):69-74.
Truog RD. Tackling medical futility in Texas. N Engl J Med. 2007;357(1):1-3.
Meadow W, Pohlman A, Frain L, et al. Power and limitations of daily prognostications of death in the medical intensive care unit. Crit Care Med. 2011;39(3):474-479.
Frick S, Uehlinger DE, Zuercher Zenklusen RM. Medical futility: predicting outcome of intensive care unit patients by nurses and doctors—a prospective comparative study. Crit Care Med. 2003;31(2):456-461.
Muni S, Engelberg RA, Treece PD, Dotolo D, Curtis JR. The influence of race/ethnicity and socioeconomic status on end-of-life care in the ICU. Chest. 2011;139(5):1025-1033.
Kramer BJ, Kavanaugh M, Trentham-Dietz A, Walsh M, Yonker JA. Predictors of family conflict at the end of life: the experience of spouses and adult children of persons with lung cancer. Gerontologist. 2010;50(2):215-225.
Okhuysen-Cawley R, McPherson ML, Jefferson LS. Institutional policies on determination of medically inappropriate interventions: use in five pediatric patients. Pediatr Crit Care Med. 2007;8(3):225-230.
Burkle CM, Benson JJ. End-of-life care decisions: importance of reviewing systems and limitations after 2 recent North American cases. Mayo Clin Proc. 2012;87(11):1098-1105.
Guo L, Schick IC. The impact of committee characteristics on the success of healthcare ethics committees. HEC Forum. 2003;15(3):287-299.
McGee G, Caplan AL, Spanogle JP, Asch DA. A national study of ethics committees. Am J Bioeth. 2001;1(4):60-64.
Fox E, Myers S, Pearlman RA. Ethics consultation in United States hospitals: a national survey. Am J Bioeth. 2007;7(2):13-25.
Smith ML, Gremillion G, Slomka J, Warneke CL. Texas hospitals’ experience with the Texas Advance Directives Act. Crit Care Med. 2007;35(5):1271-1276.
O’Callaghan N. Dying for due process: The unconstitutional medical futility provision of the Texas Advance Directives Act. Bayl Law Rev. 2008;60(2):527-611.
Chidwick P, Sibbald R, Hawryluck L. Best interests at end of life: an updated review of decisions made by the Consent and Capacity Board of Ontario. J Crit Care
. 2013;28(1):22-27. [CrossRef]
Wojtasiewicz ME. Damage compounded: disparities, distrust, and disparate impact in end-of-life conflict resolution policies. Am J Bioeth
. 2006;6(5):8-12. [CrossRef]
Rosoff PM. Institutional futility policies are inherently unfair [published online ahead of print August 19, 2012]. HEC Forum. doi:10.1007/s10730-012-9194-9.
Reignier J, Dumont R, Katsahian S, et al. Patient-related factors and circumstances surrounding decisions to forego life-sustaining treatment, including intensive care unit admission refusal. Crit Care Med
. 2008;36(7):2076-2083. [CrossRef]
Casarett D, Siegler M. Unilateral do-not-attempt-resuscitation orders and ethics consultation: a case series. Crit Care Med
. 1999;27(6):1116-1120. [CrossRef]
Fine RL, Mayo TW. Resolution of futility by due process: early experience with the Texas Advance Directives Act. Ann Intern Med
. 2003;138(9):743-746. [CrossRef]
Foster KR, Vecchia P, Repacholi MH. Risk management. Science and the precautionary principle. Science
. 2000;288(5468):979-981. [CrossRef]
Kopelman LM, Resnik DB, Weed DL. What is the role of the precautionary principle in the philosophy of medicine and bioethics? [published correction appears inJ Med Philos
. 2012;37(5):505]. J Med Philos
. 2004;29(3):255-258. [CrossRef]
Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA
. 1999;281(9):824-829. [CrossRef]